CDK13 and thyroid gland carcinoma: Julia Ramírez‐Moya et al. demonstrated that ADAR1 catalyzed the A-to-I conversion at CDK13 mRNA to enhance CSC proliferation, which provides an advantage for thyroid cancer progression [146].